Several other equities analysts have also issued reports on the stock. Numis Securities Ltd reaffirmed a buy rating and issued a GBX 900 ($11.84) price target on shares of BTG in a report on Wednesday, October 18th. Deutsche Bank AG reiterated a buy rating and set a GBX 775 ($10.19) price objective on shares of BTG in a research note on Friday, October 13th. J P Morgan Chase & Co reiterated a neutral rating on shares of BTG in a research note on Friday, October 6th. Stifel Nicolaus restated a buy rating and set a GBX 800 ($10.52) target price on shares of BTG in a research report on Wednesday, August 30th. Finally, Shore Capital restated a not rated rating on shares of BTG in a research report on Thursday, July 13th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company presently has an average rating of Buy and an average target price of GBX 771.63 ($10.15).
Shares of BTG (BTG) traded down GBX 8 ($0.11) during midday trading on Monday, reaching GBX 728 ($9.58). 310,864 shares of the company’s stock traded hands, compared to its average volume of 764,109. BTG has a twelve month low of GBX 528.36 ($6.95) and a twelve month high of GBX 779 ($10.25).
WARNING: This news story was originally published by BBNS and is owned by of BBNS. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://baseballnewssource.com/markets/btg-plc-btg-given-hold-rating-at-peel-hunt/1761560.html.
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with our FREE daily email newsletter.